“In this study we pioneered a totally new treatment for stroke, and possibly for all neurological disease”
In the latest in a series of experiments testing the use of stem cells to treat neurological disease, researchers at Henry Ford Hospital have shown for the first time that microscopic material in the cells offers a “robust” treatment for crippling stroke.
“In this study we pioneered a totally new treatment for stroke, and possibly for all neurological disease,” says Michael Chopp, Ph.D., scientific director of the Henry Ford Neuroscience Institute.
It focused on exosomes, blister-like microscopic “bubbles” that once were thought to carry and get rid of “old” proteins that were no longer needed by the body. After they were recently found to also carry RNA, whole new fields of study were suggested – including the pioneering work at Henry Ford.
The research team found that after inducing stroke in lab rats, injecting exosomes containing this genetic material into their blood prompted remodeling of the affected brain, including increased production of new brain cells, blood vessels and neural rewiring. Together, these effects significantly improved neurological function that had been impaired by stroke.
Using bone marrow from the adult rats, the researchers extracted stem cells – specifically mesenchymal cells, or MSCs – that were then employed to generate exosomes.
The researchers induced stroke by occluding an artery in the brain of each rat to block blood flow for two hours. Twenty-four hours later, they injected the exosomes into a vein in each rat’s tail.
The rats’ physical agility and neurological responses were tested before stroke and after treatment with the exosomes, and the results were compared.
“All rats showed severe functional loss one day after treatment, but gradual and eventually significant improvement during the four-week period that followed,” Dr. Chopp says. “This discovery provides a novel treatment for stroke, and possibly other neurological diseases.”
The Latest on: Treatment for Stroke
- Workflow patterns and potential for optimization in endovascular stroke treatment across the world: results from a multinational surveyon April 7, 2020 at 2:42 pm
ucalgary.ca Background The benefit of endovascular treatment (EVT) is highly time-dependent, and treatment delays reduce patients’ chances to achieve a good outcome. In this survey-based study, we ...
- Having a stroke? An emergency means call 911, even in the age of coronavirus | Columnon April 7, 2020 at 1:44 pm
Don’t let coronavirus fears keep you out of the ER if you have a life-threatening medical problem, warn three USF neurologists.
- New method of stroke treatment led to better patient careon April 7, 2020 at 12:16 pm
A new method of evaluating and prioritizing treatment for patients with suspected acute stroke, which has been used by the Stockholm health authority since 2017, has led to faster health interventions ...
- Endothelium-targeted deletion of the miR-15a/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic strokeon April 7, 2020 at 12:01 pm
Thus, preserving BBB integrity and normal function should be a valuable therapeutic approach in the treatment of ischemic stroke (4). Many factors contribute to the physical barrier of the BBB, ...
- New practices improve stroke careon April 7, 2020 at 7:30 am
A new method of evaluating and prioritising treatment for patients with suspected acute stroke, which has been used by the Stockholm health authority since 2017, has led to faster health interventions ...
- Seneca Biopharma Announces Update on Phase II Clinical Trial Underway in China for the Treatment of Ischemic Strokeon April 7, 2020 at 5:00 am
Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet ...
- Telemedicine-Based Prehospital Stroke Triage Speeds Thrombectomyon April 6, 2020 at 1:36 pm
Moreover, the 323 triage-positive stroke patients in the study received timely treatment when compared to historical controls from the previous year, when people were still being sent to the nearest ...
- Coronavirus: 2nd inmate at Massachusetts Treatment Center dies after testing positive for COVID-19on April 3, 2020 at 2:23 pm
The death is the second in the state since the coronavirus started to penetrate Massachusetts jails and prisons.
- Athersys Inc.: MultiStem Cell Therapy Is The Most Advanced And Tested Treatment For ARDS, And Thus COVID-19on April 3, 2020 at 8:45 am
In an interview Wednesday on Fox News, Athersys CEO Gil Van Bokkelen noted that Athersys is currently coordinating with the FDA to implement a large scale study ...
- Global Stroke Treatment Drugs Market 2020 Outlook, Industry Size, Share, Growth, Geographical Segmentation, Comprehensive Analysis by 2025on March 29, 2020 at 9:40 am
Global Stroke Treatment Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 incorporates the analysis of different factors that augment the market’s growth. The report ...
via Google News and Bing News